Patent EP0427680A1 successfully refreshed from Google Patents.
← Back to Patent Explorer
EP0427680A1 Expired / Lapsed EP ⏱️ 0.0 years remaining

Heteroatoms-containing tricyclic compounds

Assignee: Novartis AG
•
Filing: 1990-11-07
•
Granted: —
•
Expires: 2010-11-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention concerns the compounds of formula I wherein the substituents have various significances. They are prepared by several processes including epimerizing replacement, treatment with cyanogen bromide or thiophosgene, treatment with an acid having a non-nucleophilic anion, treatment with dimethylsulfoxide and acetic anhydride, acylation, treatment with an oxalyl derivative and ammonia, methylation, oxidation, deprotection and protection. They possess interesting pharmacological activity as antiinflammatory, immunosuppressant, antiproliferative and chemotherapeutic drug resistance reversing agents.

Inventors

  • 👤 Karl Baumann
  • 👤 Gerhard Emmer

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-02 16:16
CPC Classifications
C; C07; C07D; C07D498/00; C07D498/12; C07D498/18; A; A61; A61P; A61P17/00; A61P27/00; A61P27/02; A61P27/14; A61P29/00; A61P37/00; A61P37/02; A61P37/06; A61P37/08; C07H; C07H19/00; C07H19/01

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 1143 words
A process for the preparation of a compound of formula I wherein either R₁ is a group (a) of formula wherein R₅ is chloro, bromo, iodo or azido and R₆ is hydroxy or methoxy; R₂ is oxo and there is a single bond in 23,24 position; optionally protected hydroxy and there is a single or a double bond in 23,24 position; or absent and there is a double bond in 23,24 position; and R₄ is hydroxy and there is a single bond in 10,11 position; or absent and there is a double bond in 10,11 position; or R₁ is a group (b) or (d) of formula wherein R₆ is as defined above; R₂ is as defined above; and R₄ is hydroxy and there is a single bond in 10,11 position; or R₁ is a group (c) of formula wherein R₆ is as defined above and R₇ is oxo; optionally protected hydroxy; methoxy; methylthiomethoxy; isobutanoyloxy; aminooxalyloxy; R₈R₉CHCOO- wherein R₈ is optionally protected hydroxy or optionally protected amino and R₉ is hydrogen or methyl; or p-tolyloxythiocarbonyloxy; R₂ is oxo and there is a single bond in 23,24 position; absent and there is a double bond in 23,24 position; or is optionally protected hydroxy, methoxy, methylthiomethoxy, isobutanoyloxy, aminooxalyloxy or R₈R₉CHCOO- wherein R₈ and R₉ are as defined above, and there is a single or a double bond in 23,24 position; whereby for group (c) 1) when R₇ is oxo, unprotected hydroxy or methoxy then R₂ is other than absent and other than unprotected hydroxy or methoxy, and there is a single bond in 23,24 position; 2) when R₆ is methoxy and R₇ is methylthiomethoxy then R₂ is other than absent and other than unprotected hydroxy; 3) when R₆ is methoxy and R₇ is protected hydroxy then R₂ is other than optionally protected hydroxy; and 4) when R₆ is hydroxy then R₇ is other than optionally protected hydroxy; and R₄ is hydroxy and there is a single bond in 10,11 position; and R₃ is methyl, ethyl, n-propyl or allyl; in free form or, where such forms exist, in salt form, comprising a) for the preparation of a compound of formula I wherein R₁ is a group (a) as defined in claim 1, R₂ and R₃ are as defined in claim 1 and R₄ is hydroxy (i.e. a compound Ia ), replacing under simultaneous epimerization the hydroxy group by chlorine, bromine, iodine or azido in a corresponding compound having unprotected hydroxy in 33 position (i.e. a compound IIa , of formula IIa wherein R₂ and R₃ are as defined above under formula I and R₆ is hydroxy or methoxy); b) for the preparation of a compound of formula I wherein R₁ is a group (b) as defined in claim 1, R₂ and R₃ are as defined in claim 1 and R₄ is hydroxy (i.e. a compound Ib ), treating a corresponding compound IIa with cyanogen bromide in the presence of a base or treating a corresponding compound IIa with thiophosgene, reacting the resultant product with an inorganic azide and allowing the resultant unstable intermediate having a group in 33 position (i.e. a compound IIb ) to decompose to a corresponding compound Ib; c) for the preparation of a compound of formula I wherein R₁ is a group (d) as defined in claim 1, R₂ and R₃ are as defined in claim 1 and R₄ is hydroxy (i.e. a compound Ic ), treating a corresponding compound Ib with an acid having a non-nucleophilic anion; d) for the preparation of a compound of formula I wherein R₁ is a group (c) wherein R₆ is as defined in claim 1, one of R₂ and R₇ is oxo or methylthiomethoxy and the other is protected hydroxy, R₃ is as defined in claim 1 and R₄ is hydroxy (i.e. a compound Id ), treating a corresponding compound wherein one of the substituents in 24 and 33 position is hydroxy and the other is protected hydroxy, (i.e. a compound IIc ) with dimethylsulfoxide and acetanhydride; e) for the preparation of a compound of formula I wherein R₁ is a group (c) wherein R₆ is as,defined in claim 1 and R₇ is isobutanoyloxy, aminooxalyloxy, R₈R₉CHCOO- as defined in claim 1 or p-tolyloxythiocarbonyloxy, R₂ and R₃ are and defined in claim 1 and R₄ is hydroxy (i.e. a compound Ie ), appropriately acylating a corresponding compound IIa; f) for the preparation of a compound of formula I wherein R₁ is a group (c) wherein R₆ is as defined in claim 1 and R₇ is aminooxalyloxy, R₂ is optionally protected hydroxy or is aminooxalyloxy, R₃ is as defined in claim 1 and R₄ is hydroxy (i.e. a compound If ), treating with an appropriate oxalyl derivative and thereafter with ammonia a corresponding compound having an optionally protected hydroxy group in 33 position and a protected hydroxy group in 24 position (i.e. a compound IId ); g) for the preparation of a compound of formula I wherein R₁ is a group (c) wherein R₆ is as defined in claim 1, R₂ and R₇ are as defined in claim 1 with the proviso that one of R₂ and R₇ is methoxy, R₃ is as defined in claim 1 and R₄ is hydroxy (i.e. a compound Ig ), methylating a corresponding compound having a hydroxy group in 24 or 33 position (i.e. a compound IIe ); h) for the preparation of a compound of formula I wherein R₁ is a group (c) wherein R₆ is as defined in claim 1, R₂ and R₇ are as defined in claim 1 with the proviso that one of R₂ and R₇ is oxo, R₃ is as defined in claim 1 and R₄ is hydroxy (i.e. a compound Ih ), oxidizing a corresponding compound having a hydroxy group in 24 or 33 position (i.e. a compound IIf ); and - when a resultant compound of formula I has a protected hydroxy and/or a protected amino group, optionally splitting off the protecting group(s) to give a corresponding compound of formula I having one or more unprotected hydroxy and/or unprotected amino group(s) (i.e. a compound Ij ), whereby when R₁ is a group (a), a water molecule may be simultaneously split off and a compound of formula I is obtained wherein R₁ is a group (a) as defined in claim 1, R₂ is unprotected hydroxy and there is a single or double bond in 23,24 position; and R₄ is absent and there is a double bond in 10,11 position (i.e. a compound Ii ); or - optionally protecting an unprotected hydroxy and/or unprotected amino group in a resultant compound of formula I as appropriate to give a corresponding compound of formula I having one or more protected hydroxy and/or protected amino groups(s) (i.e. a compound Ik ); and recovering the resultant compound of formula I in free form and, where such forms exist, in salt form.
Claim 2
Dependent Claim 24 words
A process according to claim 1 for the preparation of the compound according to claim 1 which is 29-des-(4-hydroxy-3-methoxycyclohexyl)-­29-(3-formylcyclopentyl)-FR 520 (compound of Example 12).
Claim 3
Dependent Claim 31 words
A process according to claim 1 for the preparation of the compound according to claim 1 which is 33-aminooxalyloxy-FR 520 (compound of Example 28a) in free form or in salt form.
Claim 4
Dependent Claim 26 words
A process according to claim 1 for the preparation of the compound according to claim 1 which is FR 520-33-glycolate (compound of Examples 32 and 54).
Claim 5
Dependent Claim 26 words
A process according to claim 1 for the preparation of the compound according to claim 1 which is 33-isobutanoyloxy-FR 520 (compound of Examples 37 and 62).
Claim 6
Dependent Claim 24 words
A process according to claim 1 for the preparation of the compound according to claim 1 which is 33-epi-33-chloro-FR 520 (compound of Example 66a).
Claim 7
Dependent Claim 41 words
A process for the preparation of a pharmaceutical composition comprising mixing a compound of formula I as defined in claim 1 in free form or, where such forms exist, in pharmaceutically acceptable salt form, with a pharmaceutically acceptable carrier or diluent.

References Cited (Backward Citations)

EP0184162A2 Cited
EP0227355A2 Cited
EP0323042A1 Cited

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag